Discover open access scientific publications

Search, annotate, share and cite publications

Publications by R. Lanman

P1.13-37 Clinical Evaluation of Plasma-Based (cfDNA) Genomic Profiling in Over 1,000 Patients With Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

MA16.08 Clinical Utility of Detecting ROS1 Genetic Alterations in Plasma

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.09-21 Circulating Tumor DNA Improves Genotypification and Detection of Targetable Alterations in Selected Lung Cancer Patients

Journal of Thoracic Oncology

Respiratory Medicine

English

MA26.03 Activity of Osimertinib and the Selective RET Inhibitor BLU-667 in an EGFR-Mutant Patient With Acquired RET Rearrangement

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.04-11 the Influence of Circulating Tumor DNA Analysis on Response to Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.15-16 Clinical Economic Impact of Improved Genotyping in Patients With Advanced Non-Small Cell Lung Adenocarcinoma (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-28 the Clinical Impact of Comprehensive cfDNA Genomic Testing in Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

MA16.01 Frequency and Genomic Context of Emerging Markers for Molecular Testing in Lung Adenocarcinoma in Cell-Free DNA NGS Analysis

Journal of Thoracic Oncology

Respiratory Medicine

English

MA02.11 Achieving Value in Cancer Diagnostics: Blood Versus Tissue Molecular Profiling - A Prospective Canadian Study (VALUE)

Journal of Thoracic Oncology

Respiratory Medicine

English